U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
171031171031Matched Unrelated Donor Transplant for Metastatic Renal Cell CarcinomaTerminatedNo Results AvailableMetastatic Renal Cell CarcinomaProcedure: NST using MUD for metastatic renal cell carcinomahttps://ClinicalTrials.gov/show/NCT00318110
171032171032Histamine Responsiveness in McCune-Albright SyndromeRecruitingNo Results AvailableMcCune-Albright Syndromehttps://ClinicalTrials.gov/show/NCT00318097
171033171033PPI Test in GP PatientsCompletedNo Results AvailableGERDDrug: Esomeprazole|Procedure: Ambulatory 24-hour esophageal pH-monitoringhttps://ClinicalTrials.gov/show/NCT00318084
171034171034Multi MERCI (Mechanical Embolus Removal in Cerebral Ischemia [MERCIâ„¢])CompletedNo Results AvailableIschemic StrokeDevice: Merci Retrieverhttps://ClinicalTrials.gov/show/NCT00318071
171035171035Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly PopulationCompletedNo Results AvailableInfluenzaBiological: influenza vaccine Fluarix, Adjuvanted Fluarixhttps://ClinicalTrials.gov/show/NCT00318058
171036171036Effects of Optical Blur on Performance and Comfort of Computer UsersActive, not recruitingNo Results AvailableRefractive ErrorDevice: Eyeglass lenseshttps://ClinicalTrials.gov/show/NCT00318045
171037171037A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 DiabetesActive, not recruitingNo Results AvailableType 2 Diabetes MellitusDrug: multi-factorial interventionhttps://ClinicalTrials.gov/show/NCT00318032
171038171038Effect of OPC Factor on Energy LevelsCompletedNo Results AvailableHealthyDietary Supplement: OPC Factor(TM)|Other: Placebohttps://ClinicalTrials.gov/show/NCT00318019
171039171039Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus SymptomsCompletedNo Results AvailableChronic RhinosinusitisProcedure: saline irrigation|Procedure: saline sprayhttps://ClinicalTrials.gov/show/NCT00318006
171040171040LDL Receptor Under Ezetimibe and SimvastatinCompletedNo Results AvailableHealthy MenDrug: ezetimibe|Drug: simvastatin|Drug: ezetimibe plus simvastatinhttps://ClinicalTrials.gov/show/NCT00317993
171041171041Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous LeishmaniasisCompletedNo Results AvailableCutaneous LeishmaniasisDrug: Meglumine antimoniate|Drug: Meglumine antimoniatehttps://ClinicalTrials.gov/show/NCT00317980
171042171042Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the HeartCompletedNo Results AvailableHypertrophic CardiomyopathyDrug: Atorvastatin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00317967
171043171043Spironolactone in Diabetic NephropathyCompletedNo Results AvailableDiabetic NephropathyDrug: Spironolactonehttps://ClinicalTrials.gov/show/NCT00317954
171044171044Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or RebifCompletedHas ResultsRelapsing-remitting Multiple SclerosisDrug: Betaferon/Betaseron|Drug: Rebif|Drug: Betaferon/Betaseronhttps://ClinicalTrials.gov/show/NCT00317941
171045171045Efficacy of Metformin in PCOS: Metabolic and Hormonal FactorsActive, not recruitingNo Results AvailablePolycystic Ovary SyndromeDrug: Metforminhttps://ClinicalTrials.gov/show/NCT00317928
171046171046Irbesartan in Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes|Microalbuminuria|HypertensionDrug: Irbesartan treatmenthttps://ClinicalTrials.gov/show/NCT00317915
171047171047An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)CompletedNo Results AvailableAnemia|HIV InfectionsDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00317902
171048171048Compaction Total Hip Arthroplasty (THA) BilateralWithdrawnNo Results AvailableCoxarthrosisProcedure: Bone preparation technique: compaction|Procedure: Bone preparation technique: broachinghttps://ClinicalTrials.gov/show/NCT00317889
171049171049Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's AnemiaCompletedNo Results AvailableFanconi AnemiaDrug: cyclophosphamide|Drug: cyclosporine|Drug: methotrexate|Procedure: allogeneic bone marrow transplantation|Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00317876
171050171050Zink and Bone StrengthSuspendedNo Results AvailableCoxarthrosis|Fracture of Femoral Neckhttps://ClinicalTrials.gov/show/NCT00317863
171051171051Gabapentin for the Treatment of TinnitusTerminatedNo Results AvailableTinnitusDrug: Gabapentin (Neurontin)https://ClinicalTrials.gov/show/NCT00317850
171052171052Bipolar Versus Unipolar Hemiarthroplasty for Patients With a Hip FractureWithdrawnNo Results AvailableFemoral Neck FracturesProcedure: Unipolar Hemiarthroplasty of the hip joint|Procedure: bipolar hemiarthroplastyhttps://ClinicalTrials.gov/show/NCT00317837
171053171053Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDietary Supplement: ascorbic acid|Drug: bortezomib|Drug: melphalanhttps://ClinicalTrials.gov/show/NCT00317811
171054171054Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple MyelomaCompletedNo Results AvailableDrug/Agent Toxicity by Tissue/Organ|Multiple Myeloma and Plasma Cell NeoplasmBiological: anti-thymocyte globulin|Drug: sirolimushttps://ClinicalTrials.gov/show/NCT00317798
171055171055Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other DiseasesCompletedNo Results AvailableLeukemia|Lymphoma|Myelodysplastic SyndromesDrug: cyclophosphamide|Drug: cyclosporine|Drug: methotrexate|Drug: mycophenolate mofetil|Drug: sirolimus|Drug: tacrolimus|Other: pharmacological study|Procedure: allogeneic bone marrow transplantation|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00317785
171056171056Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube CancerActive, not recruitingNo Results AvailableOvarian Cancer|Peritoneal Neoplasms|Fallopian Tube CancerDrug: Topotecan|Drug: Gefitinibhttps://ClinicalTrials.gov/show/NCT00317772
171057171057Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: therapeutic autologous lymphocytes|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00317759
171058171058Trial of Citalopram for the Prevention of DepressionCompletedNo Results AvailableDepression|HIV Infections|Hepatitis CDrug: Citalopramhttps://ClinicalTrials.gov/show/NCT00317746
171059171059Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the KneeCompletedNo Results AvailableOsteoarthritis, KneeDrug: Ketoprofen in Transfersomehttps://ClinicalTrials.gov/show/NCT00317733
171060171060Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast CancerCompletedHas ResultsBreast Cancer|Neoplasm MetastasisDrug: Trastuzumab|Drug: RAD001https://ClinicalTrials.gov/show/NCT00317720

* Görseller ve İçerik tekif hakkına sahip olabilir